PMID: 9445376Mar 7, 1998Paper

Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation

The Biochemical Journal
I V TurkoJ D Corbin

Abstract

cGMP-binding phosphodiesterases contain two homologous allosteric cGMP-binding sites (sites a and b) that are arranged in tandem; they constitute a superfamily of mammalian cyclic nucleotide receptors distinct from the cyclic nucleotide-dependent protein kinases/cation channels family. The functional role of each of these two sites in the phosphodiesterases is not known. The cGMP-binding sites of one of these phosphodiesterases, the cGMP-binding cGMP-specific phosphodiesterase (cGB-PDE, PDE5), have been analysed by using site-directed mutagenesis. Mutations that affect cGMP binding to either one or both allosteric sites do not influence cGMP hydrolysis in the catalytic site under the conditions used. However, compared with wild-type enzyme, the D289A, D478A and D289A/D478A mutants, which are defective in cGMP binding to either site a or site b, or both allosteric sites, require much higher cGMP concentrations for the allosteric stimulation of phosphorylation by the catalytic subunit of cAMP-dependent protein kinase. The cGMP effect is on the cGB-PDE rather than on the catalytic subunit of the protein kinase because the latter enzyme does not require cGMP for activity. The D289N mutant, which has higher binding affinity for cGMP...Continue Reading

Citations

Dec 10, 2003·The Journal of Biological Chemistry·Kate E BroderickShireen A Davies
Jan 27, 2004·Molecular Pharmacology·Roya ZoraghiSharron H Francis
Mar 3, 2006·Molecular Pharmacology·Florian MullershausenDoris Koesling
Jan 18, 2008·The Journal of Pharmacology and Experimental Therapeutics·Emmanuel P BessayJackie D Corbin
Sep 24, 2010·The Journal of Biological Chemistry·Huanchen WangHengming Ke
Dec 3, 2011·Circulation. Heart Failure·Xiaoyin ShanKenneth B Margulies
Dec 7, 2013·Endocrine Reviews·Monalisa F AzevedoConstantine A Stratakis
Dec 13, 2017·Oncotarget·Ines BaroneStefania Catalano
Feb 8, 2006·Annual Review of Physiology·Karnam S Murthy
Feb 27, 2003·The Journal of Cell Biology·Florian MullershausenDoris Koesling
Jan 6, 2006·International Journal of Impotence Research·A MakhloufC Niederberger
Nov 30, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Dou DouYuansheng Gao
Oct 3, 1998·The Journal of Biological Chemistry·J KoteraK Omori
Aug 12, 2010·British Journal of Pharmacology·Ronald JägerMichael Russwurm
Jan 12, 2020·Pharmacology & Therapeutics·Claire LugnierBernard Geny
Nov 7, 2020·International Journal of Molecular Sciences·Agnieszka Kilanowska, Agnieszka Ziółkowska
Oct 16, 2020·Proceedings of the National Academy of Sciences of the United States of America·Juyao DongMichael S Strano
Jun 27, 1998·Biochemical and Biophysical Research Communications·P StaceyS C Phillips
Nov 14, 2001·Biochemical Pharmacology·U R SchwarzM Eigenthaler
May 14, 1999·Trends in Endocrinology and Metabolism : TEM·R B MorelandA Traish
Sep 16, 1998·Current Opinion in Chemical Biology·M J Perry, G A Higgs
Apr 15, 2021·Thrombosis and Haemostasis·Tiphaine Belleville-RollandChristilla Bachelot-Loza
Mar 17, 2009·The Journal of Sexual Medicine·Ching-Shwun Lin
May 10, 2021·Protein and Peptide Letters·Ioannis AngelisVassilios Tsikaris

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.